Total Funding
33
5
Total FundingFunding Round raised
Growth Score
-2 pts
Heat Score
-53 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
472086
ORCA Therapeutics isdesigns and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA).
- Kees Groen: CEO
- Wenliang Dong: Chief Operating Officer
About the Company
ORCA Therapeutics is a biopharmaceutical company, designs and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). The ORCA agents/oncolytic viruses are derived from naturally occurring viruses and are engineered to selectively destroy cancer cells, while healthy cells are left unharmed.
